PTC Therapeutics (BH3.MU) Q1 2026 Earnings

19FebConfirmed
Q1 2026
-1.42
-0.92
-0.41
0.09

Details

Expected EPS
0.0876069936
Actual EPS
-1.418331
Surprise EPS
-1.51
Surprise Percent
+1,718.97%

Description

PTC Therapeutics (BH3.MU) has reported earnings of -1.418331 per share for Q1 2026.

0 Comments

Share your thoughts